Digest: This Act changes the time of the report about some information from DCBS to PDAB to yearly. Changes the number of drugs PDAB must identify for cost issues. Changes PDAB's reporting about generic drugs. (Flesch Readability Score: 60.9).
[
Digest: The Act makes the State Board of Pharmacy study prescription drugs. (Flesch Readability Score: 72.6).]
[
Requires the State Board of Pharmacy to study prescription drugs. Directs the board to submit findings to the interim committees of Legislative Assembly related to health care not later than September 15, 2026.]
[
Sunsets on January 2, 2027.]
Modifies, from quarterly to annually, the timing of the Department of Consumer and Business Services' requirement to report certain information to the Prescription Drug Affordability Board.
Modifies the number of prescription drugs that may create affordability challenges that the board is directed to identify.
Modifies the board's reporting requirements for the status of the generic drug market.Statutes affected: A-Engrossed: 646A.689, 646A.696, 646A.697